Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Volato Group, Inc.Volato Group Reports $24.9 Million Revenue and $3.6 Million Net Income in Q2 2025
BRAINSTORM CELL THERAPEUTICS INC.Brainstorm Cell Therapeutics Reports Q2 2025 Financial Results with Improved Net Loss
GALECTIN THERAPEUTICS INCGalectin Therapeutics Reports Reduced Net Loss and Advances Clinical Trials in Q2 2025
Lexeo Therapeutics, Inc.Lexeo Therapeutics Reports $26.1 Million Net Loss in Q2 2025, Highlights Clinical Advancements
Onconetix, Inc.Onconetix Reports 84.9% Revenue Decline and $2.4 Million Net Loss in Latest Quarter
Advanced Flower Capital Inc.Advanced Flower Capital Inc. Reports $13.2 Million Net Loss and Strategic Expansion Plans
ABEONA THERAPEUTICS INC.Abeona Therapeutics Reports $400,000 Revenue and $108.8 Million Net Income for Quarter Ending June 30, 2025
Falcon's Beyond Global, Inc.Falcon's Beyond Reports 42% Revenue Growth and $25.11M Net Income in Q2 2025
Prelude Therapeutics IncPrelude Therapeutics Reports $31.2 Million Net Loss in Q2 2025, Seeks Additional Funding
BK Technologies CorpBK Technologies Reports Revenue Growth and Increased Profitability in Q2 2025
McGraw Hill, Inc.McGraw Hill Reports $535.7 Million Revenue and Net Income Recovery in Q2 2025
TIC Solutions, Inc.Acuren Corporation Reports Q2 2025 Revenue Growth Despite Net Loss
Chicago Atlantic BDC, Inc.Chicago Atlantic BDC Reports Significant Growth in Investment Income and Assets for Q2 2025
Werewolf Therapeutics, Inc.Werewolf Therapeutics Reports $17.98 Million Net Loss in Q2 2025, No Revenue Generated
ROCKWELL MEDICAL, INC.Rockwell Medical Reports 38% Decline in Q2 2025 Net Sales, Net Loss of $3 Million
Protalix BioTherapeutics, Inc.Protalix BioTherapeutics Reports 49% Revenue Growth and Improved Net Loss in Latest 10-Q Filing
Cellectar Biosciences, Inc.Cellectar Biosciences Reports Reduced Losses and Strategic Focus on Cancer Therapies
BIOTRICITY INC.Biotricity Reports 21% Revenue Growth and First Positive Operating Profit
Newton Golf Company, Inc.Newton Golf Company Reports Significant Revenue Growth but Widened Net Loss in Q2 2025
LITHIUM AMERICAS CORP.Lithium Americas Reports $24.8 Million Net Loss for First Half of 2025 Amid Rising Costs
FITLIFE BRANDS, INC.FitLife Brands Reports 5% Revenue Decline in Q2 2025, Acquires Irwin Naturals
Traws Pharma, Inc.Traws Pharma Reports $2.73M Revenue for Q2 2025, Net Loss Improves to $915K
reAlpha Tech Corp.reAlpha Tech Corp. Reports 1,909% Revenue Growth in Q2 2025 Amid Operating Loss
Evoke Pharma IncEvoke Pharma Reports 47% Increase in Net Product Sales Despite Ongoing Losses in Q2 2025
COMMUNITY BANCORP /VTCommunity Bancorp. Reports Increased Net Income and Loan Growth in Q2 2025